LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

Search

Smith & Nephew PLC ADR

Closed

30.47 -0.2

Overview

Share price change

24h

Current

Min

30.33

Max

30.77

Key metrics

By Trading Economics

Income

35M

331M

Sales

203M

3.2B

P/E

Sector Avg

21.217

49.052

Dividend yield

2.58

Profit margin

10.368

Employees

16,988

EBITDA

133M

856M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+5.72% upside

Dividends

By Acuity

Dividend yield

Sector Avg

2.58%

2.36%

Market Stats

By TradingEconomics

Market Cap

-2.3B

13B

Previous open

30.67

Previous close

30.47

Smith & Nephew PLC ADR Chart

Past performance is not a reliable indicator of future results.

About Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat